Sat, Feb 28, 2015, 11:22 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Molycorp, Inc. Message Board

chaulagaichet 19 posts  |  Last Activity: Feb 26, 2015 9:23 PM Member since: Aug 26, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • If this stock is determined to remain at current level, why yahoo target price is still $3?

  • chaulagaichet chaulagaichet Feb 26, 2015 9:20 PM Flag

    How about you?

  • chaulagaichet chaulagaichet Feb 24, 2015 11:33 AM Flag

    A few weeks back I placed 20,00 LLEN buy order GTC at$.05 of which 15,006 were fulfilled. The balance of 4904 is still pending while I saw other fulfillment at $.0437 which is lower than my offer price. How could it be possible? Could anyone knowledgeable on the matter explain?

  • I think KTOS should climb as high as $200 in 3 years time. I will keep on holding a few shares no matter what.

    Sentiment: Hold

  • US Officials are investigating at least 10 major banks for possible rigging of precious metals market.

    Sentiment: Strong Buy

  • Reply to

    WHO says Ebola cases increased slightly

    by chaulagaichet Feb 5, 2015 11:00 PM
    chaulagaichet chaulagaichet Feb 10, 2015 12:41 PM Flag

    Who is controlling the SP?

    Sentiment: Strong Buy

  • Reply to

    HEB: looks like a hidden Gem

    by chaulagaichet Feb 3, 2015 10:24 AM
    chaulagaichet chaulagaichet Feb 9, 2015 9:52 AM Flag

    Why Balck Rock and Vanguard are the largest share holders? I am inclined to invest in this company.

    Sentiment: Buy

  • New Executive Management, Board of Directors, and Advisory board have been put in place following the recommendation made in the above settlement document. It is a real company with real business. Former CEO has been removed but he is still the largest individual share holder.

    Sentiment: Strong Buy

  • LONDON (AP) — The number of Ebola cases in West Africa has gone up for the first time this year, the World Health Organization says, warning that the coming rainy season could complicate efforts to contain the disease.

    In an update published online Wednesday, the U.N. health agency said there were 124 confirmed cases last week, up from 99 the week before.

    WHO said there are continuing problems tracking the spread of the virus. Only 21 percent of new cases in Sierra Leone were from known contacts, meaning health officials have no idea how the majority of new patients are being infected and where the virus might be lurking.

    In Guinea, about half of new patients were from contacts of other cases, and 10 of 34 prefectures in the country reported at least one security problem or refusal to cooperate with international aid efforts in the last week. Ebola is also continuing to spread to new areas in Guinea, close to the border with Mali.

    WHO noted that a single unsafe burial in Guinea in early January sparked nearly a dozen confirmed cases. The bodies of people killed by Ebola are highly infectious and traditional burial practices that involve washing or kissing the body are extremely risky.

    "A rise in incidence shows that the (Ebola) response still faces significant challenges," WHO said, adding that the wet season will make it hard to get to remote areas.

    To date, the virus is believed to have killed nearly 9,000 people and the death rate is estimated to be between 50 and 60 percent in West Africa for people hospitalized with the disease.

    At a WHO Ebola meeting last month, the agency's chief Dr. Margaret Chan said data showed that "we have bent the (epidemic) curve and avoided the worst-case scenario," after earlier predicting there might be as many as 10,000 cases per week. She said the agency was focused on getting to zero cases but that "high-risk situations" were still occurring.

  • A registered professional analyst went beyond the professional ethical boundaries and published a non factual rumor to manipulate share price in the interest of institutional investors who had shorted more than 53 millions of MCP shares. Damage done by this act is being assessed. I just think, it is not Molycorp but DA Davinson will go bankcrupt.

  • Reply to

    HEB: looks like a hidden Gem

    by chaulagaichet Feb 3, 2015 10:24 AM
    chaulagaichet chaulagaichet Feb 3, 2015 10:33 AM Flag

    I think it is worth risking a few thousands shares. Downside risk is 30 cents per share while the sky is the upside limit.

    Sentiment: Buy

  • chaulagaichet by chaulagaichet Feb 3, 2015 10:24 AM Flag

    Despite a corrupt management, the products look like hidden gem. Mega investors like Black Rock and Vanguard do not invest in any company without doing proper research. They two still hold 15 million shares.

    Sentiment: Hold

  • chaulagaichet chaulagaichet Feb 3, 2015 9:48 AM Flag

    why you worrying so much. just take care of yourself. OK

  • In December 2011, Kyle Carter was hired as a Data Control Clerk at the annual salary of $37,950. Mr. Carter is the Son of Dr. William A. Carter, our CEO. From December 2011 through June 2012, we employed Kyle Carter and paid approximately $8,000 and $3,000 in 2012 and 2011, respectively.

    In June 2012, William Kramer was hired as a Clinical Research Associate at the annual salary of $68,284. Mr. Kramer is the Son-In-Law of Dr. William A. Carter, our CEO, and was paid approximately $38,000 in 2012 in salary. Additionally in 2012 on an as-needed basis, the Company utilized the services of Kramer Environmental Management, Inc. to develop standard operating procedures, compliance assessments, testing and
    obtain permits related to environmental issues. William Kramer is also the President of Kramer Environmental Management, Inc. and this organization was paid approximately $0, $20,000 and $0 by us during 2013, 2012 and 2011, respectively.

    Katalin Kovari, M.D. was paid approximately $26,000, $25,000 and $28,000 in 2013, 2012 and 2011, respectively, for her part-time services to the Company as Assistant Medical Director. Dr. Kovari is the spouse of Dr. William A. Carter, our CEO. Since October 2011, Peter Kovari was utilized as a part-time independent contractor for Hemispherx Biopharma Europe to undertake projects as a Clinical Programmer related to coordinating, programming, analyzing and evaluating clinical data for the Company at the rate of $20 per hour
    and was paid by us approximately $22,000, $12,000 and $6,000 in 2013, 2012 and 2011, respectively. Mr. Kovari is the nephew of Dr. Katalin Kovari, our Assistant Medical Director and spouse of Dr. William A. Carter, our CEO

  • In December 2011, Kyle Carter was hired as a Data Control Clerk at the annual salary of $37,950. Mr. Carter is the Son of Dr. William A. Carter, our CEO. From December 2011 through June 2012, we employed Kyle Carter and paid approximately $8,000 and $3,000 in 2012 and 2011, respectively.

    In June 2012, William Kramer was hired as a Clinical Research Associate at the annual salary of $68,284. Mr. Kramer is the Son-In-Law of Dr. William A. Carter, our CEO, and was paid approximately $38,000 in 2012 in salary. Additionally in 2012 on an as-needed basis, the Company utilized the services of Kramer Environmental Management, Inc. to develop standard operating procedures, compliance assessments, testing and
    obtain permits related to environmental issues. William Kramer is also the President of Kramer Environmental Management, Inc. and this organization was paid approximately $0, $20,000 and $0 by us during 2013, 2012 and 2011, respectively.

    Katalin Kovari, M.D. was paid approximately $26,000, $25,000 and $28,000 in 2013, 2012 and 2011, respectively, for her part-time services to the Company as Assistant Medical Director. Dr. Kovari is the spouse of Dr. William A. Carter, our CEO. Since October 2011, Peter Kovari was utilized as a part-time independent contractor for Hemispherx Biopharma Europe to undertake projects as a Clinical Programmer related to coordinating, programming, analyzing and evaluating clinical data for the Company at the rate of $20 per hour
    and was paid by us approximately $22,000, $12,000 and $6,000 in 2013, 2012 and 2011, respectively. Mr. Kovari is the nephew of Dr. Katalin Kovari, our Assistant Medical Director and spouse of Dr. William A. Carter, our CEO.

  • Reply to

    News - my take

    by votingmachine Feb 2, 2015 9:14 AM
    chaulagaichet chaulagaichet Feb 2, 2015 11:36 AM Flag

    in short, production increased, cost sequentially reduced, demand increasing, china is addressing it policy issue in view of environmental impact of uncontrolled or illegal production and black market export. Green light is seen far away after passing through a long dark tunnel.

  • Reply to

    MCP short interests

    by blooooooodsucker Dec 26, 2014 11:30 AM
    chaulagaichet chaulagaichet Feb 2, 2015 11:28 AM Flag

    In the stock market some kind of manipulation will never be over. If you recognize the direction of current and try to flow with it you will make progress as MCP did from $14 to $78 and then from $78 to $0.28. Buying stocks of a non proven company is purely like a gambling. It is a another form of Casino.

  • chaulagaichet chaulagaichet Jan 27, 2015 2:04 PM Flag

    If there is a pressure for covering shorts, share price will spike towards the closing today.

  • Over the down trend of last three months, the short has come down from 70 millions to 51 millions. Short data of January 15th will be released at 4 pm today. I expect this figure come down to 30 million. I think all the noise produced by socalled analysts intended to help cover shorts at cheap. Data will tell us the truth.

    Sentiment: Hold

MCP
0.9378-0.0069(-0.73%)Feb 27 4:05 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Aruba Networks, Inc.
NASDAQFri, Feb 27, 2015 4:00 PM EST